SPDR系列信託 - State Street SPDR標普生物科技ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionD.a. Davidson & Co.
Latest Disclosed Ownership8,128 shares
Latest Disclosed Value $ 1,038,303
D.a. Davidson & Co. ownership in XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On May 5, 2026 - D.a. Davidson & Co. filed a 13F-HR form disclosing ownership of 8,128 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $1,038,189 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 8,552 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. This represents a change in shares of -4.96% during the quarter. The current value of the position is $1,045,830 USD.

D.a. Davidson & Co. has a history of taking positions in derivatives of the underlying security (XBI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 8,128 -424 -4.96 1,038 -0.38 0.0063
2026-01-29 2025-12-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 8,552 -481 -5.32 1,043 15.14 0.0064
2025-10-22 2025-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 9,033 -656 -6.77 905 12.70 0.0058
2025-07-30 2025-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 9,689 -400 -3.96 804 -1.83 0.0057
2025-04-28 2025-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 10,089 -185 -1.80 818 -11.57 0.0066
2025-01-31 2024-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 10,274 -150 -1.44 925 -10.11 0.0075
2024-11-13 2024-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 10,424 -20,024 -65.76 1,030 -63.54 0.0085
2024-08-01 2024-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 30,448 -11,914 -28.12 2,823 -29.78 0.0250
2024-05-13 2024-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 42,362 30,197 248.23 4,020 270.07 0.0362
2024-02-09 2023-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 12,165 -2,012 -14.19 1,086 4.93 0.0106
2023-11-08 2023-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 14,177 -712 -4.78 1,035 -16.40 0.0112
2023-08-11 2023-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 14,889 -27 -0.18 1,239 8.98 0.0131
2023-04-25 2023-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 14,916 1,105 8.00 1,137 -0.87 0.0128
2023-02-03 2022-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 13,811 410 3.06 1,146 7.81 0.0135
2022-11-07 2022-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 13,401 1,289 10.64 1,063 18.11 0.0139
2022-07-28 2022-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 12,112 894 7.97 900 -10.71 0.0113
2022-05-12 2022-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 11,218 806 7.74 1,008 -13.55 0.0110
2022-01-31 2021-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 10,412 886 9.30 1,166 -2.67 0.0124
2021-11-15 2021-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 9,526 491 5.43 1,198 -2.04 0.0139
2021-08-10 2021-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 9,035 -1,867 -17.13 1,223 -17.31 0.0143
2021-05-07 2021-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 10,902 2,277 26.40 1,479 21.83 0.0189
2021-02-10 2020-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 8,625 148 1.75 1,214 28.47 0.0186
2020-11-02 2020-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 8,477 203 2.45 945 2.05 0.0164
2020-08-10 2020-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 8,274 4,113 98.85 926 187.58 0.0173
2020-05-05 2020-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 4,161 151 3.77 322 -15.49 0.0063
2020-02-14 2019-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 4,010 209 5.50 381 31.38 0.0062
2019-11-05 2019-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,801 -10 -0.26 290 -13.17 0.0052
2019-08-13 2019-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,811 -35 -0.91 334 -4.02 0.0062
2019-05-13 2019-03-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,846 -50 -1.28 348 24.29 0.0060
2019-01-29 2018-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,896 -80 -2.01 280 -26.51 0.0055
2018-11-13 2018-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,976 86 2.21 381 2.97 0.0068
2018-08-02 2018-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,890 115 3.05 370 11.78 0.0073
2018-05-04 2018-03-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 3,775 -380 -9.15 331 -6.23 0.0068
2018-02-08 2017-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 4,155 -275 -6.21 353 -7.83 0.0074
2017-11-08 2017-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 4,430 0 0.00 383 12.32 0.0075
2017-08-11 2017-06-30 13F SPDR S&P BIOTECH ETF COM 78464A870 4,430 1,000 29.15 341 43.88 0.0077
2017-05-12 2017-03-31 13F SPDR S&P BIOTECH ETF COM 78464A870 3,430 75 2.24 237 19.70 0.0057
2017-02-15 2016-12-31 13F SPDR S&P BIOTECH ETF COM 78464A870 3,355 3,355 198 0.0045
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-01-31 2024-12-31 13F SPDR SER TR S&P BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F SPDR SER TR S&P BIOTECH Call 1 0.00 2 100.00 n/a n/a n/a
2024-08-01 2024-06-30 13F SPDR SER TR S&P BIOTECH Call 1 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.